SSH Notice – John Christopher Lawrence

Company Announcement 30 March, 2017 SSH Notice - John Christopher Lawrence Please refer to the attached disclosure of movement for John Christopher Lawrence in TruScreen Limited ordinary shares. ENDS For more information visit www.truscreen.com Contact: Martin Dillon, TruScreen Chief Executive Officer email: martindillon@truscreen.com About TruScreen: TruScreen real time cervical cancer technology utilises a digital wand which is placed on the surface of the cervix to measure electrical and optical signals from the surrounding tissue to identify precancerous change, or cervical intraepithelial neoplasia (CIN).TruScreen has distribution contracts in a range of international markets, including China, Latin America, Central Asia, Russia, the Middle East and Eastern Europe. -ENDS- End CA:00299080 For:TRU Type:SSH Time:2017-03-30 13:08:51